SMS alerts can make the difference between a profitable trade and a missed opportunity.
 Text “MOMO” to 555888 to receive our instant, reliable and free SMS alerts.

Good morning all,

OBMP has started well this morning, hitting a high so far of $0.0163 for 20% upside on the day. 

It appears the bounce is on, and today is just the start of what could be a major move higher.

If OBMP moves back to its 50 or 100 day moving average, we could be looking at gains of 196 to 270%... And OBMP has made big moves like this before.

Take the opportunity while its still here because this afternoon and next week may be too late.

All the best.

SmallCapMomo


--------------------------------------------------------------------------------------------------


Traders and Investors,

With a few nice winners under our belt over the past couple of weeks, today I'm focusing on a proven past winner that's been beaten down and could be ready for an epic bounce higher.

The ticker I'm talking about is OncBioMune Pharmaceuticals, Inc. (OBMP).

In fact, long time members will remember I first alerted OBMP early last year. It opened at $0.20 and hit $0.25 that same day on big volume for a 25% gain. 

Even more impressive was that it went on to breakout in a big way, hitting a six month high of $0.42 just a few weeks later, for over 100% gains from our alert price.

The next time I alerted OBMP was a few months later and it recorded 20% gains.

Now OBMP is trading a mere $0.0135 - a long way from its recent trading highs.

The 50 and 100 day moving averages are around $0.04 and $0.05 respectively, and its six month high is around $0.17. 

If OBMP bounces and makes a move higher like we expect it could, there could be gains of anywhere between 196% to 1,159%!!!

Sounds crazy right? Well, maybe not so. The chart doesn't lie.

Right now OBMP is trading right near 52 week lows, and nothing about the Company's business has fundamentally has changed in recent months. In fact, based on recent press releases, it may have got even better!!

So we think OMBP has the potential to bounce big. And if some momentum comes in, maybe even a short squeeze, we could see some impressive gains to come.

Last month OBMP gained around 80% in one day, and back in August / September last year, it ran from $0.05 to almost $0.17 in just a few weeks.




Biotech continues to be one of the hottest sectors in the market, and it shows no signs of slowing down yet. 

Many small cap biotech's have been running 100, 200, even 1,000%+ in a matter of days.

And with a massively oversold pullback, OBMP could be the perfect biotech trade.

In addition, OBMP has excellent recent volume and liquidity, a tight level 2, and a small market cap and small float, a great combination for traders and investors alike.


So what's the catalyst for OBMP?

OBMP has recently been announcing some major news recently.

Just a couple days ago OBMP announced the signing of a Letter of Intent with Urology Clinics of North Texas (UCNT) for the purpose of initiating a Phase 2 Clinical Trial of ProscaVax in advanced prostate cancer patients.  ProscaVax is OncBioMune’s novel immunotherapeutic cancer vaccine consisting of a combination of prostate cancer associated prostate specific antigen (PSA) with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF).

Dr. James S. Cochran, M.D., D.A.B.U., F.A.C.S., UCNT Medical Director, has agreed to serve as the trial’s Principal Investigator.  Dr. Cochran has over 30 years of clinical practice experience and has participated in and provided oversight in more than 300 clinical trials.

“Ever since I learned of ProscaVax, I have been highly interested in its potential benefit to the thousands of prostate cancer patients with late-stage disease that face a bleak prognosis with negligible therapeutic options,” commented Dr. Cochran.  “Now that I have reviewed the data from the Phase 1 Clinical Trial, I believe this immunotherapy has the potential to be a game-changer in urology.  I am extremely eager to move this trial forward expeditiously to address an area of great unmet medical need.”

Back in January, OBMP announced some impressive follow-up data from the Company’s Phase 1a trial of ProscaVax for prostate cancer. You can read all about these results here.

You can read more of OBMP's recent announcements at https://finance.yahoo.com/quote/OBMP?p=OBMP

OncBioMune Pharmaceuticals (OBMP) is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, based on their proprietary vaccine technology designed to stimulate the immune system to attack tumor cells without damaging healthy tissue.

Their lead pipeline product, ProscaVax™, has successfully completed enrollment and vaccination of the prostate cancer patients and is collecting long-term follow-up results for the 1a portion of their Phase 1a/1b clinical trial.  Due to the impressive results and proven safety profile of ProscaVax™, OncBioMune is forgoing the 1b portion of the trial to advance ProscaVax™ into Phase 2 studies. 

A Phase 2 trial is scheduled to commence at a major Northeast U.S. university cancer research hospital evaluating ProscaVax as a front-line therapy in prostate cancer patients in the “active surveillance” category, representing the first mid-stage trial of an immunotherapeutic vaccine in this patient population. 

OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars and generics to blockbuster drugs. OncBioMune is headquartered in Baton Rouge, LA.

The prostate cancer market is a $7.1B market right now, and unfortunately one that is growing fast. OBMP is a company that could have an answer . The company's recent press releases are a signal to the world that the company has arrived, and is rapidly gaining traction on finding a much needed solution for this terrible disease.


In Conclusion...

We urge you to get OBMP on your screen now and do your research. There is plenty of information on their website and around the internet, including Yahoo! Finance and many other finance portals.

OBMP has plenty of catalysts on its side. With a massively oversold chart, great recent liquidity and volume, a tight level 2, major recent catalysts and an extremely hot sector, this could be the perfect trading storm.

A bounce back to its moving averages, or even its six month trading high, could yield gains of between 196% to 1,159%!!! You don't want to miss out on this potential.


All the best.

SmallCapMomo.com

Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity.